Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Macconell et al
Reconstitute it with a fixed volume of bacteriostatic water so the concentration lands where the protocol expects
Well-controlled Hashimoto's disease, with stable thyroid function tests and appropriate levothyroxine dosing, generally poses no barrier to GLP-1 therapy
The final word: Hims ad is an offensive move against the pharma industry ( albeit a prediction we got right in our Health Trends to Watch in 2025 report ) for their high medication prices, but it will be pitted against drugmakers own campaigns during the Super Bowl
Just be aware and ensure basic hygiene habits, which is always a good practice.
2027 (The Triple-Hormone Peak): This looks like the "Year of Eli Lilly." Their triple-action Retatrutide (GIP + GLP-1 + Glucagon) is targeting a launch, alongside Boehringer Ingelheims Survodutide
30074-7/asset/5367a357-b6ae-4d9a-9e38-d2422800e400/main.assets/gr3_lrg.jpg)
30194-9/asset/e2a34f3b-6f8a-425f-9e34-2cf394cbb616/main.assets/gr4_lrg.jpg)
00459-9/asset/e4c0896a-ac7a-460c-8a8f-e5b97bab8187/main.assets/gr2_lrg.jpg)